Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Felicity J. Gabbay"'
Autor:
Phillip D. Monk, Jody L. Brookes, Victoria J. Tear, Toby N. Batten, Clare Newall, Marcin Mankowski, Michael G. Crooks, Dave Singh, Rekha Chaudhuri, Brian Leaker, Kerry Lunn, Sophie Reynolds, Sarah Dudley, Felicity J. Gabbay, Stephen T. Holgate, Ratko Djukanovic, Thomas MA Wilkinson
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-17 (2024)
Abstract Background Respiratory viral infections are major drivers of chronic obstructive pulmonary disease (COPD) exacerbations. Interferon-β is naturally produced in response to viral infection, limiting replication. This exploratory study aimed t
Externí odkaz:
https://doaj.org/article/0e45758b1a514217839b388bd5252764
Autor:
Phillip D. Monk, Jody L. Brookes, Victoria J. Tear, Toby N. Batten, Marcin Mankowski, Tatjana Adzic-Vukicevic, Michael G. Crooks, Davinder P.S. Dosanjh, Monica Kraft, Christopher E. Brightling, Felicity J. Gabbay, Stephen T. Holgate, Ratko Djukanovic, Tom M.A. Wilkinson
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Background Despite the availability of vaccines and therapies, patients are being hospitalised with coronavirus disease 2019 (COVID-19). Interferon (IFN)-β is a naturally occurring protein that stimulates host immune responses against most viruses,
Externí odkaz:
https://doaj.org/article/59ef7b2928b0495c936fac3cc3b5d606
Autor:
Peter D. Stonier, Honorio Silva, Alan Boyd, Domenico Criscuolo, Felicity J. Gabbay, Kyoko Imamura, Gustavo Kesselring, Sandor Kerpel-Fronius, Heinrich Klech, Ingrid Klingmann
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
The evolution of postgraduate vocational education and training in pharmaceutical medicine is described alongside the growth of this scientific-medical discipline and profession for the development of new medicines. Over the past 50 years, whilst the
Externí odkaz:
https://doaj.org/article/5c5c849ca0f144cbaa29e8d2992f024d
Autor:
Phillip D. Monk, Jody L. Brookes, Victoria J. Tear, Toby N. Batten, Marcin Mankowski, Tatjana Adzic-Vukicevic, Michael G. Crooks, Davinder P.S. Dosanjh, Monica Kraft, Christopher E. Brightling, Felicity J. Gabbay, Stephen T. Holgate, Ratko Djukanovic, Tom M.A. Wilkinson
Publikováno v:
ERJ Open Research. 9:00605-2022
BackgroundDespite the availability of vaccines and therapies, patients are being hospitalised with coronavirus disease 2019 (COVID-19). Interferon (IFN)-β is a naturally occurring protein that stimulates host immune responses against most viruses, i
Autor:
Pedro Mb Rodrigues, Marcin Mankowski, Salman Siddiqui, Angela Thompson, Ratko Djukanovic, Davinder Dosanjh, Najib M. Rahman, Richard J Marsden, Victoria Tear, Sandra Aitken, Toby N Batten, Jody Brookes, Alastair Watson, Tristan W Clark, Tom Wilkinson, Dave Singh, Sophie Hemmings, Lorcan McGarvey, Michael G. Crooks, Phillip Monk, Felicity J Gabbay, Stephen T. Holgate, Tim Harrison, Edmund Foster, Donna E. Davies, Adam Fleet, Ling-Pei Ho, Alex Horsley, Sarah Dudley, Dinesh Saralaya, Rona Beegan, Jacklyn A Smith
Publikováno v:
The Lancet Respiratory Medicine
Monk, P D, Marsden, R J, Tear, V J, Brookes, J, Batten, T N, Mankowski, M, Gabbay, F J, Davies, D E, Holgate, S T, Ho, L-P, Clark, T, Djukanovic, R, Wilkinson, T M A & Group, I I B COVID S 2021, ' Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial ', The Lancet. Respiratory medicine, vol. 9, no. 2, pp. 196—206 . https://doi.org/10.1016/s2213-2600(20)30511-7
Monk, P D, Marsden, R J, Tear, V J, Brookes, J, Batten, T N, Mankowski, M, Gabbay, F J, Davies, D E, Holgate, S T, Ho, L-P, Clark, T, Djukanovic, R, Wilkinson, T M A & Group, I I B COVID S 2021, ' Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial ', The Lancet. Respiratory medicine, vol. 9, no. 2, pp. 196—206 . https://doi.org/10.1016/s2213-2600(20)30511-7
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection carries a substantial risk of severe and prolonged illness; treatment options are currently limited. We assessed the efficacy and safety of inhaled nebulised interferon
Autor:
Kyoko Imamura, Gustavo Kesselring, Domenico Criscuolo, Peter David Stonier, Sandor Kerpel-Fronius, Ingrid Klingmann, Heinrich Klech, Felicity J. Gabbay, Alan Boyd, Honorio Silva
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
The evolution of postgraduate vocational education and training in pharmaceutical medicine is described alongside the growth of this scientific-medical discipline and profession for the development of new medicines. Over the past 50 years, whilst the